» Articles » PMID: 29282114

Risk Factors for Addiction Among Patients Receiving Prescribed Opioids: a Systematic Review Protocol

Overview
Journal Syst Rev
Publisher Biomed Central
Date 2017 Dec 29
PMID 29282114
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Opioid addiction prevention has become an urgent public health priority, with several countries declaring a state of emergency due to rising death tolls from opioid abuse. Reducing the risk of developing addiction among opioid-naïve patients exposed to prescribed opioids during the process of medical care may be an important primary prevention strategy. Our objective is to synthesize the available evidence about factors associated with the development of addiction among patients first exposed to prescribed opioids, with a focus on opioid-naïve patients.

Methods: We will perform a systematic search of MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and other databases in collaboration with a health information specialist using a comprehensive search strategy. We will also supplement our search with a scan of the grey literature to identify relevant ongoing and unpublished studies. We will include studies reporting on risk factors for opioid addiction in patients prescribed opioid analgesic therapy through a prescription from a licensed medical professional, with a focus on opioid-naïve patients. We will exclude studies focusing on patients who are first exposed to illicit opioids, those who use prescription opioids for cancer pain, and/or who are palliative. Two reviewers will independently review titles, abstracts, and full texts for inclusion and exclusion criteria. They will then extract data from included full texts using standardized piloted data extraction forms and assess study quality through risk of bias assessment. We will synthesize the effect sizes of risk factors derived from clinically homogenous studies with similar designs and the remaining ones qualitatively.

Discussion: Understanding risk factors for opioid addiction among patients who require analgesia has the potential to inform clinical care and opioid prescribing guidelines aiming to reduce opioid addiction. We will also use this information as a starting point for developing interventions for primary prevention.

Citing Articles

Impact of Prescription Opioid Detoxification on Quality of Life and Pain Levels.

Laubner Sakalauskiene G, Straznickaite I, Miskinyte S, Zdanavicius L, Sipylaite J, Badaras R Clin Pract. 2024; 14(4):1529-1537.

PMID: 39194927 PMC: 11353111. DOI: 10.3390/clinpract14040123.


Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences.

Muriel J, Barrachina J, Del Barco G, Carvajal C, Escorial M, Margarit C Front Pharmacol. 2023; 14:1200430.

PMID: 37324467 PMC: 10264765. DOI: 10.3389/fphar.2023.1200430.


Predicting Patient Satisfaction With Medications for Treating Opioid Use Disorder: Case Study Applying Natural Language Processing to Reviews of Methadone and Buprenorphine/Naloxone on Health-Related Social Media.

Omranian S, Zolnoori M, Huang M, Campos-Castillo C, McRoy S JMIR Infodemiology. 2023; 3:e37207.

PMID: 37113381 PMC: 9987197. DOI: 10.2196/37207.


Latin American Pain Federation position paper on appropriate opioid use in pain management.

Santos Garcia J, Gomez Lopez M, Barros G, Muniz H, Olea M, Bonilla P Pain Rep. 2019; 4(3):e730.

PMID: 31583347 PMC: 6749915. DOI: 10.1097/PR9.0000000000000730.


Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis.

Compton W, Jones C, Baldwin G, Harding F, Blanco C, Wargo E Am J Public Health. 2019; 109(S3):S185-S189.

PMID: 31242006 PMC: 6595524. DOI: 10.2105/AJPH.2019.305020.


References
1.
Fishbain D, Cole B, Lewis J, Rosomoff H, Steele Rosomoff R . What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008; 9(4):444-59. DOI: 10.1111/j.1526-4637.2007.00370.x. View

2.
Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin J . Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003; 80(1):92-105. PMC: 3456111. DOI: 10.1093/jurban/jtg092. View

3.
Turk D, Swanson K, Gatchel R . Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008; 24(6):497-508. DOI: 10.1097/AJP.0b013e31816b1070. View

4.
Wachholtz A, Gonzalez G, Boyer E, Naqvi Z, Rosenbaum C, Ziedonis D . Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Subst Abuse Rehabil. 2014; 2:145-62. PMC: 3846312. DOI: 10.2147/SAR.S12944. View

5.
Lynskey M, Fergusson D . Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use. J Abnorm Child Psychol. 1995; 23(3):281-302. DOI: 10.1007/BF01447558. View